Asia‐Pacific Psychiatry最新文献

筛选
英文 中文
Differentiating the association between age of alcohol use initiation and conditional suicidal behaviors among adolescents 区分青少年开始饮酒的年龄与有条件自杀行为之间的关联。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2024-03-21 DOI: 10.1111/appy.12554
Meiqi Wang MD, Yunxi Zhong MD, Yifan Chen MD, Qixiu Li MD, Xiaoying Su MD, Zhen Wei PhD, Long Sun PhD
{"title":"Differentiating the association between age of alcohol use initiation and conditional suicidal behaviors among adolescents","authors":"Meiqi Wang MD,&nbsp;Yunxi Zhong MD,&nbsp;Yifan Chen MD,&nbsp;Qixiu Li MD,&nbsp;Xiaoying Su MD,&nbsp;Zhen Wei PhD,&nbsp;Long Sun PhD","doi":"10.1111/appy.12554","DOIUrl":"10.1111/appy.12554","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Suicide and early alcohol use initiation are public health concerns. Previous studies have explored the associations between age of alcohol use initiation and suicidal behaviors, which progresses from ideation to action. Distinguishing between the various associations can help gain a deeper understanding of suicidal behaviors and aid in developing social suicide prevention strategies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study utilized the Youth Risk Behavior Survey to investigate this association. A total of 17 209 students were finally included in the study. Conditional suicidal behaviors included no suicidal behavior (NS), suicidal ideation without a plan or attempt (SINPA), suicide plan without an attempt (SPNA) and suicide attempt (SA).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 17 209 students, the prevalence of suicidal ideation, suicide plan, and suicide attempt were 21.4%, 17.3%, and 11.1%, respectively. Moreover, 15.2% of the students used alcohol before age 13, whereas 31.7% of students used alcohol at age 13 or older. Compared to NS, students using alcohol showed significant associations with SA (OR = 2.34, <i>p</i> &lt; .001; OR = 1.29, <i>p</i> &lt; .01), SPNA (OR = 1.68, <i>p</i> &lt; .001; OR = 1.19, <i>p</i> &lt; .05) and SINPA (OR = 1.55, <i>p</i> &lt; .001; OR = 1.40, <i>p</i> &lt; .001). Comparing with SINPA and SNPA, students using alcohol before age 13 were associated with SA (OR = 1.61, <i>p</i> &lt; .001; OR = 1.46, <i>p</i> &lt; .001), whereas those using alcohol at or after the age 13 were not associated with SA (OR = 0.98, <i>p</i> &gt; .05; OR = 1.09, <i>p</i> &gt; .05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>This study demonstrated that early alcohol use initiation was significantly associated with suicide attempts among students with suicidal ideations or plans.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"16 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of COVID-19 on emergency department presentations for mental health disorders in Queensland, Australia: A time series analysis COVID-19 对澳大利亚昆士兰州精神疾病急诊就诊率的影响:时间序列分析。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2024-03-11 DOI: 10.1111/appy.12553
Philip M. Jones BSc, MBBS, MBiostat, FACEM, Amy Sweeny BSc, RN, MPH, Grace Branjerdporn PhD, BOccThy(Hons I), CHIA, CertIV Tesol, Gerben Keijzers MBBS, MSc, FACEM, PhD, Andrea P. Marshall RN, PhD, Ya-Ling Huang RN, PhD, Emma J. Hall BN, GradCertCritCareNurs, Jamie Ranse BNurs, GradCertClinEd, GradCertClinEpi, MCritCareNurs, PhD, Dinesh Palipana OAM, LLB, GradDipLP, MD, EMC, Yang D. Teng PhD, MD, Julia Crilly OAM, BN, MEmergN(Hons), PhD, the COVERED COVID study investigators
{"title":"The impact of COVID-19 on emergency department presentations for mental health disorders in Queensland, Australia: A time series analysis","authors":"Philip M. Jones BSc, MBBS, MBiostat, FACEM,&nbsp;Amy Sweeny BSc, RN, MPH,&nbsp;Grace Branjerdporn PhD, BOccThy(Hons I), CHIA, CertIV Tesol,&nbsp;Gerben Keijzers MBBS, MSc, FACEM, PhD,&nbsp;Andrea P. Marshall RN, PhD,&nbsp;Ya-Ling Huang RN, PhD,&nbsp;Emma J. Hall BN, GradCertCritCareNurs,&nbsp;Jamie Ranse BNurs, GradCertClinEd, GradCertClinEpi, MCritCareNurs, PhD,&nbsp;Dinesh Palipana OAM, LLB, GradDipLP, MD, EMC,&nbsp;Yang D. Teng PhD, MD,&nbsp;Julia Crilly OAM, BN, MEmergN(Hons), PhD,&nbsp;the COVERED COVID study investigators","doi":"10.1111/appy.12553","DOIUrl":"10.1111/appy.12553","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The COVID-19 pandemic has been associated with detrimental effects on mental health and psychological well-being. Although multiple studies have shown decreases in mental health-related Emergency Department (ED) presentations early in the COVID-19 pandemic, the medium-term effects on mental health-related ED presentations have remained less clear. This study aimed to evaluate the effect of the pandemic on mental health ED presentations by comparing observed presentation numbers to predictions from pre-pandemic data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective cohort study tallied weekly ED presentations associated with mental health disorders from a state-wide minimum dataset. Three time periods were identified: Pre-Pandemic (January 1, 2018–March 8, 2020), Statewide Lockdown (March 9, 2020–June 28, 2020), and Restrictions Easing (June 29, 2020–June 27, 2021). Time series analysis was used to generate weekly presentation forecasts using pre-pandemic data. Observed presentation numbers were compared to these forecasts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Weekly presentation numbers were lower than predicted in 11 out of 16 weeks in the Statewide Lockdown period and 52 out of 52 weeks in the Restrictions Easing period. The largest decrease was seen for anxiety disorders (Statewide Lockdown: 76.8% of forecast; Restrictions Easing: 36.4% of forecast), while an increase was seen in presentations for eating disorders (Statewide Lockdown: 139.5% of forecast; Restrictions Easing: 194.4% of forecast).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Overall weekly mental health-related presentations across Queensland public EDs were lower than expected for the first 16 months of the COVID-19 pandemic. These findings underline the limitations of emergency department provision of mental health care and the importance of alternate care modalities in the pandemic context.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"16 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/appy.12553","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140100945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis 胃泌素与初发药物治疗无效的重度抑郁症患者的抑郁症状:下丘脑-垂体-肾上腺轴的中介作用。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2024-02-13 DOI: 10.1111/appy.12552
Chuhao Zhang MSc, Yeqing Dong PhD, ShuHua Li PhD, Meijuan Li PhD, Ying Gao MSc, Yuan Liu PhD, Xueying Liu MSc, Chi Zhou MSc, Jie Li MD, PhD
{"title":"Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis","authors":"Chuhao Zhang MSc,&nbsp;Yeqing Dong PhD,&nbsp;ShuHua Li PhD,&nbsp;Meijuan Li PhD,&nbsp;Ying Gao MSc,&nbsp;Yuan Liu PhD,&nbsp;Xueying Liu MSc,&nbsp;Chi Zhou MSc,&nbsp;Jie Li MD, PhD","doi":"10.1111/appy.12552","DOIUrl":"10.1111/appy.12552","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Major depressive disorder (MDD) is one of the global burdens of disease, and its pathogenesis remains unclear. An increasing amount of research indicates that ghrelin regulates mood in patients with MDD. Still, current results are inconsistent, and the mechanisms underlying how ghrelin modulates depressive symptoms are inconclusive, especially in first-episode drug-naïve MDD patients. Therefore, this study aims to investigate the relationship and potential mechanism between ghrelin and first-episode drug-naïve MDD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Ninety first-episode drug-naïve MDD patients and 65 healthy controls (HCs) were included. Hamilton Depression Scale (HAMD-17) as a measure of depressive symptoms. Plasma levels of ghrelin and hypothalamic–pituitary–adrenal axis (HPA-axis) hormones were measured in all participants.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Compared to HCs, the ghrelin levels were higher in the MDD (<i>p</i> &lt; .001) and still showed significance after covarying for sex, age, and Body Mass Index (BMI). Ghrelin was positively related to corticotropin-releasing-hormone (CRH) levels (<i>r</i> = .867, <i>p</i> &lt; .001), adrenocorticotropic hormone (ACTH) levels (<i>r</i> = .830, <i>p</i> &lt; .001), and cortisol levels (<i>r</i> = .902, <i>p</i> &lt; .001) in partial correlation analysis. In addition, there was a positive correlation between HAMD total score and ghrelin levels (<i>r</i> = .240, <i>p</i> = .026). Other than that, the HAMD total score also had a positive correlation with the CRH (<i>r</i> = .333, <i>p</i> = .002) and cortisol (<i>r</i> = .307, <i>p</i> = .004) levels. Further mediation analysis demonstrated that the relationship between ghrelin and HAMD total score was mediated by CRH (ab-path; <i>β</i> = .4457, 95% CI = 0.0780–1.0253, c-path; <i>β</i> = .2447, <i>p</i> = .0260, c′-path; <i>β</i> = −.2009, <i>p</i> = .3427).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These findings revealed that plasma ghrelin provides a pivotal link to depressive symptoms in first-episode drug-naive MDD patients. CRH mediated the relationship between ghrelin and HAMD total score. It might provide new insights into understanding the pathogenesis of MDD, contributing to intervention and treatment from this approach.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"16 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel 在澳大利亚建立冰毒诊所:专家小组的实用建议和临床指导。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-11-06 DOI: 10.1111/appy.12550
Nicollette L. R. Thornton BA/BSc, BHlthSc (Hons), Warwick Black MBBS, FRANZCP, Adrian Bognar BNurs, Daniel Dagge MBBS, FRANZCP, Teresia Gitau BNurs, Bruce Hua BPharm, Gero Joks PharmD, MSc, PhD, MBA, Jarrad King BSc, MIPH, Andrew Lord BPharm (Hons), Elizabeth M. Scott BSc, MBBS, FRANZCP, DMedSc, Jelena Smit Callander BNurs, GradCertMHlthN, Serena Ting BNurs, Dennis Liu MBBS, PhD, FRANZCP
{"title":"Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel","authors":"Nicollette L. R. Thornton BA/BSc, BHlthSc (Hons),&nbsp;Warwick Black MBBS, FRANZCP,&nbsp;Adrian Bognar BNurs,&nbsp;Daniel Dagge MBBS, FRANZCP,&nbsp;Teresia Gitau BNurs,&nbsp;Bruce Hua BPharm,&nbsp;Gero Joks PharmD, MSc, PhD, MBA,&nbsp;Jarrad King BSc, MIPH,&nbsp;Andrew Lord BPharm (Hons),&nbsp;Elizabeth M. Scott BSc, MBBS, FRANZCP, DMedSc,&nbsp;Jelena Smit Callander BNurs, GradCertMHlthN,&nbsp;Serena Ting BNurs,&nbsp;Dennis Liu MBBS, PhD, FRANZCP","doi":"10.1111/appy.12550","DOIUrl":"10.1111/appy.12550","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Major depressive disorder (MDD) can have severe impacts on function and quality of life. Up to one third of patients will have an inadequate response to their first line of treatment, with subsequent lines of therapy associated with lower remission rates and higher relapse rates. Recently esketamine has become available for Australian patients, and this agent provides an additional treatment option for those with MDD who have had an inadequate response to two or more antidepressant therapies during the current moderate to severe depressive episode. This paper provides an expert panel's practical recommendations and clinical guidance for establishing esketamine clinics in Australia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An expert panel (<i>n</i> = 11) comprising psychiatrists, mental health care nurses, pharmacists, and individuals with experience establishing esketamine clinics was convened in Sydney. The panel developed practical recommendations and clinical guidance, which were then further refined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Five key areas were identified: practical considerations for esketamine clinic set-up, including multidisciplinary care considerations; patient selection; administering esketamine; adverse event management and long-term follow-up.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Guidance presented in this paper should assist Australian clinicians to set up an esketamine clinic, and provide practical advice on the infrastructure and clinical requirements for treatment of patients with this agent.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/appy.12550","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71477493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Editor in Chief 来自主编。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-11-02 DOI: 10.1111/appy.12551
Allan Tasman MD
{"title":"From the Editor in Chief","authors":"Allan Tasman MD","doi":"10.1111/appy.12551","DOIUrl":"10.1111/appy.12551","url":null,"abstract":"","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71420256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double-blind, placebo-controlled study) 除标准护理外,艾司他明鼻喷雾剂对有主动自杀意念的重度抑郁症患者的疗效和安全性:ASPIRE I亚洲队列的亚组分析(一项随机、双盲、安慰剂对照研究)。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-09-28 DOI: 10.1111/appy.12548
Jin Pyo Hong MD, PhD, Akramul Zikri Abd Malek MBBS, Dr (Psych), Cheng-Ta Li MD, PhD, Jong-Woo Paik MD, PhD, Ahmad Hatim Sulaiman MBBS, MPM, PhD, Gilbert Madriaga DPT, MSc, Jianmin Zhuo PhD, Sarah Siggins PhD, Dong-Jing Fu MD, PhD, Po-Chung Ju PhD
{"title":"Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double-blind, placebo-controlled study)","authors":"Jin Pyo Hong MD, PhD,&nbsp;Akramul Zikri Abd Malek MBBS, Dr (Psych),&nbsp;Cheng-Ta Li MD, PhD,&nbsp;Jong-Woo Paik MD, PhD,&nbsp;Ahmad Hatim Sulaiman MBBS, MPM, PhD,&nbsp;Gilbert Madriaga DPT, MSc,&nbsp;Jianmin Zhuo PhD,&nbsp;Sarah Siggins PhD,&nbsp;Dong-Jing Fu MD, PhD,&nbsp;Po-Chung Ju PhD","doi":"10.1111/appy.12548","DOIUrl":"10.1111/appy.12548","url":null,"abstract":"<p>This post-hoc analysis evaluated the efficacy and safety of intranasal esketamine in the Asian subgroup from ASPIRE I. Patients with major depressive disorder and suicidal ideation with intent received intranasal esketamine (<i>n</i> = 26) or placebo (<i>n</i> = 27), plus standard of care for 25 days. The primary endpoint was the change in Montgomery-Åsberg Depression Rating Scale (MADRS) total score from baseline to Day 2. The MADRS score improved in favor of esketamine (least squares mean difference: −3.8). No unexpected safety concerns were noted. The Asian subgroup showed a similar efficacy and safety profile as the total ASPIRE I cohort.</p>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41096030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and enablers to access and utilization of mental health care services across Southeast Asia: A preliminary scoping review 东南亚地区获得和利用心理健康护理服务的障碍和促成因素:初步范围审查。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-09-21 DOI: 10.1111/appy.12549
Sleiman Andary B. Physio (Hons), Jason Bassani B. Physio (Hons), Gus Burrell B. Physio (Hons), Eliza Cole B. Physio (Hons), Rhiannon Evans B. Physio (Hons), Emily Redman B. Physio (Hons), Saravana Kumar B. App.Sc (Physio), Grad Dip (Digital Learning), MPT (Manipulative and Sports), PhD
{"title":"Barriers and enablers to access and utilization of mental health care services across Southeast Asia: A preliminary scoping review","authors":"Sleiman Andary B. Physio (Hons),&nbsp;Jason Bassani B. Physio (Hons),&nbsp;Gus Burrell B. Physio (Hons),&nbsp;Eliza Cole B. Physio (Hons),&nbsp;Rhiannon Evans B. Physio (Hons),&nbsp;Emily Redman B. Physio (Hons),&nbsp;Saravana Kumar B. App.Sc (Physio), Grad Dip (Digital Learning), MPT (Manipulative and Sports), PhD","doi":"10.1111/appy.12549","DOIUrl":"10.1111/appy.12549","url":null,"abstract":"<p>While the importance of mental health and its impact on overall health and well-being has been widely recognized, there continue to be ongoing barriers to accessing mental health services. This is particularly poignant in countries in Southeast Asia (SEA) where there may be further stigma in accessing mental health services. As no reviews have been undertaken on this topic, this review aims to outline the barriers and enablers to access and utilization of mental health care services in SEA. Searches were undertaken in commercially produced and gray literature sources. Two independent reviewers screened the results. The data were then independently extracted, which was then collated and synthesized, using the Health Belief Model (HMB) as a framework. Twelve studies were included in the review. Under the HBM, barriers were grouped into: stigma, poor health literacy, internalized reasons, cultural beliefs, lack of training of health professionals, quality of service, and poor distribution of resources. Enablers included: social support, outreach services, structural stigma, self-awareness, resources and information, accessibility and affordability, and positive attitudes and beliefs about health professionals. Those accessing mental health care in SEA are confronted by complex barriers and few enablers. Ongoing stigma and a distinct lack of resources pose the greatest challenges, which are even more amplified for those in rural areas and minority groups. A multifaceted strategy that improves the structures, processes, and outcomes of mental health is required within these communities.</p>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/appy.12549","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41113165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alexithymia in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates, and relationship with neurocognition and empathy 中国慢性精神分裂症患者述情障碍:患病率、临床相关性及其与神经认知和共情的关系
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-08-28 DOI: 10.1111/appy.12547
Pu Peng MD, Dongmei Wang PhD, Qianjin Wang PhD, Yanan Zhou PhD, Yuzhu Hao PhD, Shubao Chen PhD, Qiuxia Wu PhD, Tieqiao Liu PhD, Xiangyang Zhang PhD
{"title":"Alexithymia in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates, and relationship with neurocognition and empathy","authors":"Pu Peng MD,&nbsp;Dongmei Wang PhD,&nbsp;Qianjin Wang PhD,&nbsp;Yanan Zhou PhD,&nbsp;Yuzhu Hao PhD,&nbsp;Shubao Chen PhD,&nbsp;Qiuxia Wu PhD,&nbsp;Tieqiao Liu PhD,&nbsp;Xiangyang Zhang PhD","doi":"10.1111/appy.12547","DOIUrl":"10.1111/appy.12547","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alexithymia is highly prevalent and strongly related to adverse consequences in patients with schizophrenia. However, its associated factors remain largely unexplored. The present study aimed to determine the prevalence of alexithymia and its association with sociocultural characteristics, clinical symptoms, neurocognition, and empathy in 854 Chinese patients with schizophrenia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Demographic information was collected through a self-designed questionnaire. Alexithymia was assessed by the Toronto Alexithymia Scale (TAS-20). We assessed clinical symptoms, neurocognition, and empathy via the following instruments: Positive and Negative Syndrome Scale, Repeatable Battery for the Assessment of Neuropsychological Status, and Interpersonal Reactivity Index. A multiple logistic regression model was conducted to determine the independent correlates of alexithymia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Approximately one-third (<i>n</i> = 277, 32%) of patients with schizophrenia had alexithymia. Patients with alexithymia had significantly more severe negative symptoms, neurocognition, and empathy impairment than patients without alexithymia. Being male, negative symptoms, personal distress, empathic concern, and language functioning were independently associated with alexithymia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Our findings demonstrate a high prevalence of alexithymia and its strong association with clinical symptoms, neurocognition, and empathy, which calls for timely screening and intervention for alexithymia in patients with schizophrenia. Targeting impaired language function, negative symptoms, and impaired affective empathy might help reduce alexithymia and its related negative consequences.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the Adverse Impact of Social Determinants of Mental Health: Yet Another Call to Action 解决心理健康的社会决定因素的不利影响:又一次行动呼吁
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-08-22 DOI: 10.1111/appy.12545
Allan Tasman MD
{"title":"Addressing the Adverse Impact of Social Determinants of Mental Health: Yet Another Call to Action","authors":"Allan Tasman MD","doi":"10.1111/appy.12545","DOIUrl":"10.1111/appy.12545","url":null,"abstract":"","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 2-3","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10065343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of suicide with psychiatric hospitalization in Taiwan 台湾自杀与精神病院之关系。
IF 3.5 3区 医学
Asia‐Pacific Psychiatry Pub Date : 2023-08-21 DOI: 10.1111/appy.12546
Jia-Chi Shan MD, MHS, Mei-Chih Meg Tseng MD, PhD, Chin-Hao Chang PhD
{"title":"Association of suicide with psychiatric hospitalization in Taiwan","authors":"Jia-Chi Shan MD, MHS,&nbsp;Mei-Chih Meg Tseng MD, PhD,&nbsp;Chin-Hao Chang PhD","doi":"10.1111/appy.12546","DOIUrl":"10.1111/appy.12546","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>A knowledge gap exists in the relationship between suicide and psychiatric hospitalization in Asia. This study investigated inpatient service utilization before suicide and suicide risk at different periods of hospitalization in Taiwan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Using the National Health Insurance Research Database, we applied a nested case–control design with controls being alive on the date each case died by suicide.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 56 939 suicide cases and 1 138 780 controls were included (2:1 male-to-female ratio). Only 5.7% of suicide cases had a history of psychiatric hospitalization in the preceding year. Patients with a history of psychiatric hospitalization were associated with a higher risk of inpatient and postdischarge suicide than those without prior hospitalization. The risk was greatest in the first postdischarge week, decreased gradually, and remained significantly elevated over 7 years after discharge. The suicide risk increased more in females. Patients with affective disorders had higher inpatient and postdischarge suicide risks than those with schizophrenia spectrum disorders.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>A low rate of psychiatric hospitalization before suicide implies that inpatient treatment of psychiatric disorders could be enhanced. Community-based approaches to suicide prevention can improve the treatment utilization of those with suicide risk and bridge continuous care from hospital to community.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8618,"journal":{"name":"Asia‐Pacific Psychiatry","volume":"15 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信